Pfizer, Lilly to resume study testing pain drug

March 23, 2015 1:55 PM

6 0

Pfizer, Lilly to resume study testing pain drug

(Reuters) - Pfizer Inc and Eli Lilly and Co will resume a late-stage study testing their pain drug tanezumab after the U.S. Food and Drug Administration lifted a partial hold on it.

Pfizer expects to receive a $200 million upfront payment from Lilly as a result of the development, the companies said on Monday.

Also read: Saudi's Arab National Bank Q4 profit falls 4.9 pct, misses forecasts

Read more

To category page

Loading...